CagriSema Prices
Also known as Cagrilintide/semaglutide; NNC0174-0833
7 listings from 6 vendors, normalised to one honest price per milligram.
Cheapest per mg
$1.85/mg
At
Huatai Peptide
Vendors
6
Sizes
5mg, 10mg, 10mg Kit (10 vials), 20mg
Disclosure. Some vendors below are Peptul partners and pay us a commission when you buy through our link. Rows here are ordered by price per milligram only - paying us never moves a vendor up. Current discount codes are shown on the full price board.
CagriSema price per mg by vendor
Prices last collected August 19, 2026.
| Vendor | Size | Price | Per mg | |
|---|---|---|---|---|
| Huatai PeptideVerified COA | 10mg Kit (10 vials) | $185.00 | $1.85 | View |
| Peptide Shop Canada | 10mg | $79.68 | $7.97 | View |
| SimplePeptideVerified COAShips USOut of stock | 20mg | $178.00 | $8.90 | View |
| Coastal PeptidesVerified COAShips US | 10mg | $98.00 | $9.80 | View |
| Modern AminosVerified COAShips US | 10mg | $111.20 | $11.12 | View |
| Toronto PeptidesVerified COA | 10mg | $230.00 | $23.00 | View |
| Toronto PeptidesVerified COA | 5mg | $125.00 | $25.00 | View |
About CagriSema
- What it is
- CagriSema is an investigational once-weekly injectable that combines the amylin analog cagrilintide with the glucagon-like peptide-1 receptor agonist semaglutide in a single product. It has completed phase 3 trials for chronic weight management and type 2 diabetes, and a new drug application has been filed with the FDA. It is not yet approved, and regulatory review is ongoing.
- How it works
- It pairs an amylin receptor agonist with a GLP-1 receptor agonist to reduce appetite and food intake through two complementary pathways.
- Researched for
- Obesity; weight management; type 2 diabetes
- Half-life
- Not established
- Familiarity
- Intermediate
- Research evidence
- Human trials - phase 2 or 3
- Regulatory status
- Phase 3
- Key risk
- The semaglutide component carries a boxed warning for thyroid C-cell tumors and is contraindicated with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
For educational and research purposes only. Not medical advice. Always consult a qualified healthcare provider before using any research compound.